Porton Pharma Solutions Ltd. (SHE:300363)

China · Delayed Price · Currency is CNY

23.38

0.00 (0.00%)

At close: Feb 24, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Small Molecule Api Business	2.74B	3.47B	-	-	-
Small Molecule Api Business Growth	-20.97%	-	-	-	-
Emerging Business	242.56M	180.02M	-	-	-
Emerging Business Growth	34.74%	-	-	-	-
Other Operations	29.80M	20.72M	79.13M	15.75M	39.46M
Other Operations Growth	43.81%	-73.82%	402.41%	-60.08%	-3.70%
Chemical Drug R&D and Production Services	-	-	6.96B	3.09B	2.03B
Chemical Drug R&D and Production Services Growth	-	-	125.15%	52.01%	34.57%
Total	3.01B	3.67B	7.03B	3.11B	2.07B
Total Growth	-17.87%	-47.87%	126.55%	49.87%	33.56%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Overseas	2.23B	2.81B	6.32B	2.43B	1.75B
Overseas Growth	-20.75%	-55.52%	160.59%	38.76%	36.37%
China	783.42M	855.33M	712.63M	679.03M	323.45M
China Growth	-8.41%	20.02%	4.95%	109.94%	20.14%
Total	3.01B	3.67B	7.03B	3.11B	2.07B
Total Growth	-17.87%	-47.87%	126.55%	49.87%	33.56%

Source: S&P Global Market Intelligence.